Yuto Hirano

Mr. Yuto Hirano


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2025 in Fermentation
Verified
Journal Article
Open access
PDF file
JHJohan Hariwitonang
Johan Hariwitonang
YMYutaka Makizaki
Yutaka Makizaki
NFNao Fujiyama
Nao Fujiyama
YHYuto Hirano
Yuto Hirano
SISeigo Iwama
Seigo Iwama
Hiroshi KitagakiHiroshi Kitagaki
Hiroshi Kitagaki
Investigation of the influence of alive or dead dietary lactic acid bacteria, specifically Lactobacillus gasseri, on mice fed a tyrosine-rich diet was conducted in this study. Mice fed a tyrosine-rich diet exhibited increased p-cresol levels in the serum and cecum and deteriorated skin characteristics in terms of skin moisture and transepidermal water loss. These conditions were partially ameliorated by the intake of lactic acid bacteria. To gain insight into the mechanism, the intestinal microbiota of mice fed lactic acid bacteria was examined. The results revealed an increase in bacteria including genus Faecalibacterium and Lactobacillus in fecal samples from mice fed lactic acid bacteria. Muribaculaceae was most associated with the added group of alive or dead L. gasseri. These findings indicate that lactic acid bacteria inhibit the conversion of tyrosine to p-cresol in the colon, thereby ameliorating skin disorders.

7 June 2024 in Life
Verified
Journal Article
Open access
PDF file
HDHuanghuang Dai
Huanghuang Dai
JHJohan Hariwitonang
Johan Hariwitonang
NFNao Fujiyama
Nao Fujiyama
CMChihiro Moriguchi
Chihiro Moriguchi
YHYuto Hirano
Yuto Hirano
Hiroshi KitagakiHiroshi Kitagaki
Hiroshi Kitagaki
Skin barrier function, prevent colon cancer, head and neck cancer, and decrease liver cholesterol. However, the mechanism of action has not yet been elucidated. In this study, we propose a new working hypothesis regarding the health benefits and functions of glucosylceramide: decreased fecal hardness. This hypothesis was verified using an in vitro hardness test. The hardness of feces supplemented with glucosylceramide was significantly lower than that of the control. Based on these results, a new working hypothesis of dietary glucosylceramide was conceived: glucosylceramide passes through the small intestine, interacts with intestinal bacteria, increases the tolerance of these bacteria toward secondary bile acids, and decreases the hardness of feces, and these factors synergistically result in in vivo effects. This hypothesis forms the basis for further studies on the health benefits and functions of dietary glucosylceramides.